Dr Francisco Diaz-Mitoma
President and chief executive officer
Variations Biotechnologies inc.

Created in 2001, Variation Biotechnologies is a company whose mission is to create intelligent vaccines that learn from nature using bioinformatics. By analyzing thousands of viral sequences isolated from infected individuals worldwide, scientists have identified regions of the virus that are most vulnerable to immune-based therapies. Using its proprietary Variosite technology, Variation biotechnologies produces synthetic vaccines that represent the diversity of viral sequences in these variable regions, an approach that differs from all past and current vaccine strategies.

Past Recipients